<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04406974</url>
  </required_header>
  <id_info>
    <org_study_id>Lokalrecidiv i VGR</org_study_id>
    <nct_id>NCT04406974</nct_id>
  </id_info>
  <brief_title>Locally Advanced Colorectal Cancer and Local Recurrences in Västra Götaland</brief_title>
  <official_title>Locally Advanced Colorectal Cancer and Recurrence After Colorectal Cancer in Region Västra Götaland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to review the treatment strategies of locally advanced colorectal
      cancer and locally recurrent rectal cancer in Västra Götaland during 1995-2016. The aim is to
      evaluate time trends and outcome both related to morbidity and cancer specific survival, we
      will also evaluate the results after advanced reconstruction. The study will identify the
      population using the Swedish ColoRectal Cancer Registry and then the individual patient
      charts will be reviewed. The data will be collected in a clinical record form covering
      demography (age, sex, co-morbidity, BMI and diagnoses) as well as treatments strategy,
      surgical procedures, re-operations, complications, readmissions, hospital stay, stoma
      formation etc.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival after local recurrence</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for local recurrence</measure>
    <time_frame>Preoperative data, about 1 month prior surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications after urinary reconstruction surgery for locally advanced cancer</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient experiences after local recurrence</measure>
    <time_frame>3 years postopeartively after local recurrence</time_frame>
    <description>Indepth interviews with patients with local recurrence</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Patients with local recurrence</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with advanced colorectal cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery or treatment for local recurrence</intervention_name>
    <description>Surgery or treatment for local recurrence</description>
    <arm_group_label>Patients with advanced colorectal cancer</arm_group_label>
    <arm_group_label>Patients with local recurrence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery for advanced colorectal cancer</intervention_name>
    <description>Surgery for advanced colorectal cancer</description>
    <arm_group_label>Patients with advanced colorectal cancer</arm_group_label>
    <arm_group_label>Patients with local recurrence</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated in Region Västra Götaland 1995-2018 for colorectal cancer will be
        identified using the local Swedish Colorectal Cancer Registry. Further selection will
        depend on the primary outcome in substudies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Locally advanced rectal cancer

          -  Local recurrence for colorectal cancer

          -  Curative treatment for colorectal cancer

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eva Angenete, MD. PhD</last_name>
    <phone>0760514441</phone>
    <email>eva.angenete@vgregion.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept. of Surgery, Sahlgrenska University Hospital/Ostra</name>
      <address>
        <city>Gothenburg</city>
        <zip>SE 416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Angenete, MD,PhD</last_name>
      <phone>+46313438410</phone>
      <email>eva.angenete@vgregion.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 24, 2020</study_first_submitted>
  <study_first_submitted_qc>May 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Eva Angenete</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

